Operational dissection of β-amyloid cytopathic effects on cultured neurons

Journal of Neuroscience Research

Volumn 91, Issue 5, 2013, Pages 706-716

  Callizot, Noelle ^a   Combes, Maud ^a   Steinschneider, Rémy ^a   Poindron, Philippe ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

amyloid peptide; Alzheimer disease; Mitochondrial lesions; Neuronal death; Oxidative stress; Synapses loss

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DAMAGE; CELL DEATH; CYTOTOXICITY; ENTORHINAL CORTEX; HIPPOCAMPUS; MITOCHONDRION; NERVE CELL; NEURITE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CATALASE; CELLS, CULTURED; CEREBRAL CORTEX; CYTOCHROMES C; EMBRYO, MAMMALIAN; FEMALE; HIPPOCAMPUS; METHIONINE; NERVE NET; NEURONS; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PREGNANCY; RATS; RATS, WISTAR; SYNAPSES;

EID: 84874812665     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23193     Document Type: Article

References (31)

1. Bitan G, Vollers SS, Teplow DB. 2003. Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem 278: 34882-34889.
2. Caughey B, Lansbury PT. 2003. Protofibrils, pores, fibrils and neurodegeneration: separating protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267-298.
3. De Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT. 2012. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73: 685-697.
4. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280: 17294-17300.
5. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26: 6011-6018.
6. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M. 2009. Induction of cerebral beta-amyloidosis: intracerebral vs. systemic Abeta inoculation. Proc Natl Acad Sci U S A 106: 12926-12931.
7. Emerit J, Edeas M, Bricaire F. 2004. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58: 39-46.
8. Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
9. Harrison NL. 1990. On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol 422: 433-446.
10. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52: 831-843.
11. Jan A, Hartley DM, Lashuel HA. 2010. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat Protoc 5: 1186-1209.
12. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
13. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG. 2007. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 26: 18.
14. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C. 2009. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284: 4230-4237.
15. Kelly JS. 1999. Alzheimer's disease: the tacrine legacy. Trends Pharmacol Sci 20: 127-129.
16. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL. 2009. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 106: 4012-4017.
17. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. 2006. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
18. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K. 2012. Trans-synaptic spread of tau pathology in vivo. PLoS One 7: e31302.
19. Longo FM, Massa SM. 2004. Neuroprotective strategies in Alzheimer's disease. NeuroRx 1: 117-127.
20. Moskovitz J. 2005. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr Pharm Des 11: 1451-1457.
21. Murphy MP. 2009. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13.
22. Nimchinsky EA, Sabatini BL, Svoboda K. 2002. Structure and function of dendritic spines. Annu Rev Physiol 64: 313-353.
23. Rui Y, Tiwari P, Xie Z, Zheng JQ. 2006. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 26: 10480-10487.
24. Rui Y, Gu J, Yu K, Hartzell HC, Zheng JQ. 2010. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution. Mol Brain 26: 10.
25. Sakono M, Zako T. 2010. Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277: 1348-1358.
26. Selkoe DJ. 2008. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192: 106-113.
27. Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG. 2010. Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 27: 5-7.
28. Singer C, Figueroa-Masot X, Batchelor R, Dorsa D. 1999. Mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19: 2455-2463.
29. Tomic JL, Pensalfini A, Head E, Glabe CG. 2009. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35: 352-358.
30. Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE. 2005. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 25: 1071-1080.
31. Zempel H, Mandelkow EM. 2012. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton. Neurodegener Dis 10: 64-72.